Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Non-cash Items: 2022-2024

Historic Non-cash Items for bioAffinity Technologies (BIAF) over the last 1 years, with Mar 2024 value amounting to $243,097.

  • bioAffinity Technologies' Non-cash Items fell 10.39% to $243,097 in Q1 2024 from the same period last year, while for Mar 2024 it was $243,097, marking a year-over-year decrease of 10.39%. This contributed to the annual value of $158,332 for FY2023, which is 3.61% down from last year.
  • As of Q1 2024, bioAffinity Technologies' Non-cash Items stood at $243,097, which was up 53.54% from $158,332 recorded in Q4 2023.
  • bioAffinity Technologies' Non-cash Items' 5-year high stood at $647,793 during Q3 2022, with a 5-year trough of $158,332 in Q4 2023.
  • Its 3-year average for Non-cash Items is $287,185, with a median of $254,225 in 2023.
  • Data for bioAffinity Technologies' Non-cash Items shows a maximum YoY slumped of 60.76% (in 2023) over the last 5 years.
  • Over the past 3 years, bioAffinity Technologies' Non-cash Items (Quarterly) stood at $164,255 in 2022, then dropped by 3.61% to $158,332 in 2023, then decreased by 10.39% to $243,097 in 2024.
  • Its Non-cash Items stands at $243,097 for Q1 2024, versus $158,332 for Q4 2023 and $254,225 for Q3 2023.